Navigation Links
Dialysis Via Fistulas May Help Young or Old
Date:3/13/2009

Technique is underutilized in the U.S., expert says,,,,

FRIDAY, March 13 (HealthDay News) -- A new study finds that people with chronic kidney disease, whether young or old, respond equally well to dialysis done through arteriovenous (AV) fistulas, surgically created passageways between veins and arteries to help in the circulation of filtered blood.

In calling AV fistulas the "gold standard of access for kidney dialysis patients," one of the study's authors said the findings show that the pathways last longer, require less repair work, and are linked to lower rates of infections, hospitalization and death than other types of dialysis.

"AV fistulas are underutilized in the United States, yet they are best for keeping blood vessels open for access so individuals can continue to get their lifesaving dialysis," Dr. Andrew R. Forauer, an interventional radiologist at Dartmouth-Hitchcock Medical Center in Lebanon, N.H., said in a news release from the Society of Interventional Radiology. Forauer's findings were presented Monday in San Diego during the society's annual meeting.

When a person's kidneys fail, a dialysis machine takes over for the damaged organs, filtering wastes and extra fluids from the blood and then returning the clean blood to the body.

An AV fistula provides an access way for the blood to get in and out, with surgeons joining a vein and an artery in the forearm so that blood from the artery can flow into the vein. The increased blood flow makes the vein grow larger and stronger so it can be used for repeated needle insertions, providing an efficient pathway for the blood before and after treatment.

In the United States, however, many of those with chronic kidney failure instead have dialysis done with the blood passing in and out through synthetic bridge grafts, which Forauer said tend to clot or malfunction, increasing discomfort, inconvenience, and even death rates for dialysis patients.

In a study involving 72 people, half older than 75 and the rest between 40 and 60, the researchers found that the AV fistulas retained the same patency, or openness, in each age group.

"Elderly patients' arteriovenous (AV) fistulas responded just as well as those in younger patients in length of time the access stayed open and in moving blood flow efficiently," Forauer said. "An AV fistula is the preferred access at any age."

An estimated 27 million people in the United States have chronic kidney disease. About 500,000 are being treated for kidney failure, which requires dialysis up to three times a week or a kidney transplant to live.

More information

The National Kidney Foundation has more about dialysis.



-- Kevin McKeever



SOURCE: Society of Interventional Radiology, news release, March 9, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Clinical trials present better alternatives for dialysis patients
2. Nighttime Home Dialysis a Boon for Kidney Patients
3. Nations Largest Dialysis Patient Organization Recognizes the Achievements of Patients and Leaders in Kidney Care
4. WellBound Teams With Kaiser Permanente to Open New Self-Care Dialysis Center in Sacramento, CA
5. New peritoneal dialysis diagnostic discovered
6. Early intervention dramatically improves outcomes for new dialysis patients
7. Dialysis Corporation of America Announces Third Quarter 2007 Earnings Release Date
8. Renal Solutions, Inc. Announces FDA 510(k) Clearance of New Design of the Allient(R) Sorbent Hemodialysis System for Chronic and Acute Hemodialysis
9. DaVita Emergency Response Efforts Ensure Vital Treatment for More than 700 Kidney Failure Patients in Need of Life-Saving Dialysis Treatments in Areas Affected by Southern California Wildfires
10. DaVita to Open First Independent Dialysis Clinic in Fargo-Moorhead
11. Home Dialysis Clinical Research Study is Underway - Focuses on At-Home Extended Duration Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Dialysis Via Fistulas May Help Young or Old
(Date:1/18/2017)... ... 18, 2017 , ... Catalent Pharma Solutions, the leading global ... health products, today announced that Mr. Michael Merges, Director of Strategic Growth, Catalent ... held at the Mayflower Hotel, Washington DC, on Jan. 24 – 26, 2017. ...
(Date:1/18/2017)... ... January 18, 2017 , ... Floundering on New Year’s ... and the perfect time for a reset. The U.S. Apple Association agrees and recommends ... many of the factors that contribute to heart disease. , The U.S. Apple Association ...
(Date:1/17/2017)... ... January 17, 2017 , ... For breast cancer clinicians and ... or those who desire a more intimate review and analysis of its highlights, a ... to Bedside—is being offered by Imedex on February 4, 2017 in Chicago. Chaired by ...
(Date:1/17/2017)... ... January 17, 2017 , ... Etymotic ... National Association of Music Merchants (NAMM) winter trade show, Booth #2876, at the ... ER•4® has long been the gold standard for high-definition, in-ear earphones. This classic ...
(Date:1/17/2017)... ... January 17, 2017 , ... Peoples Health is ... Health network on Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, ... an exciting addition to our provider network, and the addition will benefit our ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017  Dermata Therapeutics, ... products to treat a variety of dermatological diseases, ... compound DMT210, in a Phase 2 acne rosacea ... to downregulate the proinflammatory cytokines in the skin ... acne rosacea. This clinical trial, ...
(Date:1/18/2017)... 18, 2017 The report " Automated Breast Ultrasound System ... Scanner), By End User (Hospitals, Diagnostic Imaging Centers), Industry Analysis Report, Regional Outlook ... Argentina , Germany , UK, France ... Russia , China , Japan , ... , Saudi Arabia , UAE, South Africa ...
(Date:1/18/2017)... , Jan. 18, 2017  Tarix Orphan LLC today ... granted a Rare Pediatric Disease (RPD) designation for the ... Dystrophic Epidermolysis Bullosa (RDEB), a rare genetic skin disorder. ... treatment is limited to supportive care. "The ... Drug Designation previously granted by the FDA in this ...
Breaking Medicine Technology: